The ESN360 Academy is a non-promotional medical education programme for epilepsy specialist nurses (ESNs) from the UK and Ireland. The two-day; in-person launch event will include a series of interactive presentations and workshops led by a committee of expert nurses and guest speakers. Attendees will hear from experts on how to handle difficult epilepsy cases and understand the role of nurses in the implementation of epilepsy guidelines. Attendees will also take part in a series of practical knowledge exchange workshops; learning about the management of risk; the diagnosis of epilepsy in different populations; co-morbidities; and ESN career development.
At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life.
We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies.
We pledge to successfully develop distinctive treatments for CNS, Mental Health disorders, Rare Diseases while preserving our leading position in the Consumer Health segment.
